Skip to content
July 02, 2022

Equity.Guru

Investment information for the new generation

NAVB.NYSE

Feliz Navidea $29.79M Market Capitalization Navidea Biopharmaceuticals Inc. (NAVB.NYSE) announced today that it has received regulatory approval in India for its Lymphoaim, also referred to as Lymphoseek in the…